
WILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF SALE OF OPERATING SUBSIDIARY AND MANAGEMENT CHANGES
CALGARY, AB, April 30, 2025 /CNW/ - Willow Biosciences Inc. (the " Company") (TSX: WLLW) (OTCQB: CANSF) announces the completion today of the sale (the " Transaction") of its wholly-owned operating subsidiary, Epimeron USA, Inc., to the U.S. subsidiary of Mycofeast Ltd., a privately-held, arms-length entity based in the United Kingdom (the " Purchaser"), pursuant to the terms of a share purchase agreement dated March 14, 2025 (the " Share Purchase Agreement"), between the Company and the Purchaser.
The Transaction was completed for aggregate consideration equal to US$2.76 million in cash following closing adjustments (the " Purchase Price"), of which US$275,975 (the " Escrow Amount") is subject in escrow until September 17, 2025, at which point the Company and the Purchaser will jointly instruct the escrow agent to pay the Company the balance of the Escrow Amount in excess of any amounts subject to indemnity claims and certain post-closing price adjustments. There is no guarantee that all or any portion of the Escrow Amount will be payable to the Company.
The Company intends to apply a portion of the Purchase Price to debt reduction, and will retain the remainder pending a review of its futures cash requirements and potential opportunities, with a view to maximizing shareholder value. Additional information concerning the Transaction is disclosed in the Company's management information circular dated March 26, 2025 (the " Information Circular"). Copies of the Share Purchase Agreement and the Information Circular are available on the Company's SEDAR+ profile at www.sedarplus.ca.
As a condition to the completion of the Transaction, Dr. Chris Savile, President and Chief Executive Officer of the Company, and Dr. Trish Choudhary, Senior Vice President, Research and Development, resigned from their roles with the Company to join the Purchaser. Travis Doupe, Chief Financial Officer of the Company, has been appointed to the role of Interim Chief Executive Officer effective today. The Company's board of directors wishes to thank Dr. Savile and Dr. Choudhary for their service and wishes them both all the best in their future endeavours.
Forward-Looking Statements. This news release may include forward-looking statements including opinions, assumptions, estimates and the Company's assessment of future plans and operations, and, more particularly, without limitation, statements concerning: anticipated use of proceeds from the Transaction; receipt of the Escrow Amount by the Company; and potential future opportunities. When used in this news release, the words "will," "anticipate," "believe," "estimate," "expect," "intent," "may," "project," "should," and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded on the basis of expectations and assumptions made by the Company. Forward-looking statements are subject to a wide range of risks and uncertainties, and although the Company believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
32 minutes ago
- Cision Canada
Pet Valu Holdings Ltd. Announces C$576 Million Secondary Bought Deal Offering
Base shelf prospectus is accessible, and prospectus supplement will be accessible within two business days, on SEDAR+ /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ MARKHAM, ON, June 3, 2025 /CNW/ - Pet Valu Holdings Ltd. ("Pet Valu" or the "Company") (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, announced today that PV Holdings S.à r.l., Roark Capital Partners II AIV AG, L.P., RCPS Equity Cayman LP and Roark Capital Partners Parallel II AIV AG, L.P. (collectively, the "Selling Shareholders"), have entered into an agreement with RBC Capital Markets and CIBC Capital Markets (the "Underwriters") to complete a secondary offering on a bought deal basis (the "Offering"). Under the agreement, the Underwriters have agreed to purchase 19,969,450 common shares ("Common Shares") of the Company at a purchase price of C$28.85 per Common Share for total gross proceeds to the Selling Shareholders of approximately C$576 million. The net proceeds of the Offering will be paid directly to the Selling Shareholders. The Company will not receive any proceeds from the Offering. The Common Shares will be offered by way of a prospectus supplement to the short form base shelf prospectus of the Company dated August 15, 2024 in all of the provinces and territories of Canada and may also be offered by way of private placement in the United States. The Offering is expected to close on or about June 9, 2025, subject to customary closing conditions. Following the completion of the Offering, the Selling Shareholders will no longer own any common shares of Pet Valu. As a result, the investor rights agreement (the "Investor Rights Agreement") between the Company and the Selling Shareholders, which provided the Selling Shareholders with certain contractual rights related to, among other things, the nomination of directors of the Company, will terminate in accordance with its terms. Clayton Harmon, Patrick Hillegass and Kevin Hofmann are nominees of the Selling Shareholders on the board of directors of the Company pursuant to the Investor Rights Agreement. In connection with the termination of the Investor Rights Agreement, the Company anticipates that Clayton Harmon will resign as a director, and Patrick Hillegass and Kevin Hofmann will continue as directors of the Company pending identification by the board of directors of suitable replacement directors. Richard Maltsbarger, Chief Executive Officer of Pet Valu, commented, "this transaction marks a significant milestone after a successful relationship between Pet Valu and Roark. We extend our sincere gratitude to Roark who, as franchise business model specialists, helped transform Pet Valu from a regional 350-store network into Canada's largest pet specialty retailer serving millions of devoted pet lovers annually. Their expertise, stewardship, and patience enabled us to make multi-year investments in people, processes, and systems to drive growth." "With an unmatched, national omni-channel presence and modernized supply chain, Pet Valu is very well positioned to continue its strong track record of growth," continued Mr. Maltsbarger. "We expect to continue to deliver compelling returns to our shareholders and franchisee owners as we pursue our mission to be Canada's preferred pet retailer." Clayton Harmon, Managing Director at Roark Capital Management, LLC, added, "we wish Richard, Linda, Greg, and everyone at Pet Valu all the best. With its high-quality brand, franchisees, team, and shareholders, we look forward to watching its continued success in the years ahead." The Common Shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered, sold or delivered, directly or indirectly, in the United States (as such term is defined in Regulation S under the U.S. Securities Act) or to, or for the account or benefit of, U.S. Persons (as defined in the U.S. Securities Act), except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or solicitation of an offer to buy any Common Shares in any jurisdiction in which the offering or sale is not permitted. Access to the prospectus supplement, the base shelf prospectus and any amendments to the documents is provided in accordance with securities legislation relating to procedures for providing access to a prospectus supplement, a base shelf prospectus and any amendment. The base shelf prospectus is, and the prospectus supplement will be (within two business days of the date hereof), accessible on SEDAR+ at An electronic or paper copy of the prospectus supplement, the base shelf prospectus and any amendment to the documents may be obtained, without charge, from RBC Dominion Securities Inc., Attention: Distribution Centre, 180 Wellington Street West, 8th Floor, Toronto, ON M5J 0C2 or by email at [email protected] or CIBC Capital Markets, 161 Bay Street, 5th Floor, Toronto, ON M5J 2S8 or by telephone at 416-956-6378 or by email at [email protected] by providing the contact with an email address or address, as applicable. The base shelf prospectus and prospectus supplement contain important, detailed information about the Company and the proposed Offering. Prospective investors should read the base shelf prospectus and prospectus supplement (when filed) before making an investment decision. About Pet Valu Pet Valu is Canada's leading retailer of pet food and pet-related supplies with over 800 corporate-owned or franchised locations across the country. For more than 45 years, Pet Valu has earned the trust and loyalty of pet parents by offering knowledgeable customer service, an extensive product offering and engaging in-store services. Through its local neighbourhood stores and digital platform, Pet Valu offers more than 10,000 competitively-priced products, including a broad assortment of exclusive, holistic and award-winning proprietary brands. The Company is headquartered in Markham, Ontario, and has distribution centres in Brampton, Ontario, Surrey, British Columbia and Calgary, Alberta. Its shares trade on the Toronto Stock Exchange (TSX: PET). To learn more, please visit: Forward-Looking Information Some of the information contained in this press release is forward-looking information. Forward-looking information is provided as at the date of this press release and is based on management's opinions, estimates and assumptions in light of its experience and perception of historical trends, current trends, current conditions and expected future developments, as well as other factors that management believes appropriate and reasonable in the circumstances. Such forward-looking information is intended to provide information about management's current expectations and plans, and may not be appropriate for other purposes. Pet Valu does not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable Canadian securities laws. Actual results and the timing of events may differ materially from those anticipated in the forward-looking information as a result of various factors and assumptions, and subject to the risks as set out in the Company's annual information form dated March 3, 2025 and as discussed under "Risk Factors" in the prospectus supplement and short form base shelf prospectus.

Cision Canada
2 hours ago
- Cision Canada
NYSE Content Advisory: NYSE, Money20/20, FINTECH.TV, and Cheddar create "Taking Stock"
NEW YORK, June 3, 2025 /CNW/ -- The New York Stock Exchange (NYSE), Money20/20, and Cheddar announced the launch of "Taking Stock," a new, social first content series airing daily. The show was announced from the Money20/20 Europe main stage, marking a new era in fintech media. Broadcasting from the NYSE, the show will feature a mix of breaking news, expert insights, and interactive social media integration, hosted by award-winning journalist J.D. Durkin with contributions from others. The series will deliver on-location reporting from top fintech events around the world, spotlighting both major industry players and rising startups to a combined potential audience of over 12 million. With backing from four leading media entities, Taking Stock aims to make fintech accessible and engaging, blending business, culture, and technology through authentic storytelling and audience interaction. Premiering in mid-August, the show will deliver live segments, interviews, and cross-platform content focused on demystifying fintech and making it informative, entertaining, and community-driven. SOURCE New York Stock Exchange Joe Benarroch, [email protected], Head of Content, Media Partnerships, & Distribution


Vancouver Sun
2 hours ago
- Vancouver Sun
Cowan: Future is hazy for Canadiens centre Kirby Dach
Kent Hughes knew the Canadiens had a lack of depth at the centre position when he took over as GM three years ago. That's why at his first NHL Entry Draft as GM in 2022, Hughes traded a first-round pick and a third-round pick to the Chicago Blackhawks in exchange for Kirby Dach. 'We were looking to improve, get a little bigger, faster in the middle of the ice if we could,' Hughes said after making the trade. 'There's also, in a perfect world, an age component to it so that (Dach) can grow with our young core, and certainly he fit that description for us. We knew he was available potentially, so we spent a good amount of time trying to understand who Kirby Dach was. He went third pick overall (at the 2019 NHL Draft). What's happened with Kirby Dach? Why is Chicago willing to move him? 'I've said it all along, we're going to invest money in developing hockey players and trying to get the most out of their potential, and we believe Kirby has significant potential,' Hughes added. 'We think with the Montreal Canadiens, in this environment, can bring him along and get him to a point where he can be a pretty special centreman.' Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. Three years later, there are more questions than answers when it comes to the 24-year-old Dach. As a result, Hughes will head into this off-season once again looking for a second-line centre who can play behind captain Nick Suzuki, either through free agency or a trade. Dach had 10-12-22 totals and was a team-worst minus-29 before suffering a season-ending injury to his right knee that required surgery for the second straight year. He won only 40.3 per cent of his faceoffs. The top centres eligible to become free agents on July 1 are Florida's Sam Bennett, 29, Toronto's John Tavares , 34, Colorado's Brock Nelson , 33, and Dallas's Matt Duchene , 34. Their salary demands will probably be too high for the Canadiens, even if those players had any interest in coming to Montreal. A trade for a younger centreman with NHL experience seems a more likely scenario. Jeff Gorton, the Canadiens' executive vice-president of hockey operations, didn't rule out the possibility of making offer sheets to restricted free agents during a season-ending news conference last month and added he and Hughes weren't limited to looking only at centres to improve their top-six forward situation, which is a priority. The Canadiens had interest in right-winger Jonathan Marchessault as a free agent last summer, but weren't willing to offer the 34-year-old more than a three-year contract. Instead, Marchessault signed a five-year, US$27.5-million deal with Nashville that has an annual salary-cap hit of US$5.5 million and then the 5-foot-9, 185-pounder posted 21-35-56 totals with the Predators. Frank Seravalli of Daily Faceoff reported last week that Marchessault is open to being traded after the Predators finished 30th in the overall NHL standings, with Montreal a favourable landing spot. But the length of Marchessault's contract must still be a concern for Hughes. Dach is heading into the final season of his contract with a US$3.36 million salary-cap hit. 'I still believe in Kirby,' Hughes said at the season-ending news conference with Gorton. 'He has so much potential as a player.' Hughes wouldn't say this is Dach's last chance with the Canadiens, but added it's a very important season for the centre and that he and the team know that. Hughes spoke with Dach during his exit meeting about the importance of him doing everything possible this summer so he can show up at training camp in the best state possible, physically and mentally. Hughes noted that constant negative comments in a hockey market like Montreal can be like 'an avalanche' for a young player who is struggling on the ice. Hughes also said the fact Dach was coming back from a serious knee injury — torn ACL and MCL ligaments in his right knee that limited him to two games in 2023-24 — can't be overlooked and pointed out that while Dach was minus-29 last season, he was minus-2 when he played 58 games during his first season with the Canadiens in 2022-23, posting 14-24-38 totals. 'Obviously, he's had two really tough years and two tough injuries here,' Gorton said about Dach. 'We're going to have to see how he responds this summer to the rehab and going through this again. But there's certainly a place for him in our lineup. It's going to be up to him where that's going to be. He has size, he's competitive, he's got skill, he's a very talented player. I think a lot is in the balance of how his summer goes, with how the rehab's going to go. We saw last year, last season, a slow start coming back from that (injury) particularly in his skating, and he'd be the first to tell you that. 'I think a lot, unfortunately, is going to be what kind of summer he has and what kind of start he has to camp,' Gorton added. 'He's going to need a big camp to get himself going and get started early.'